 Connection
Michael Bristow to Histamine H2 Antagonists
This is a "connection" page, showing publications Michael Bristow has written about Histamine H2 Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.783 |
|
|
|
-
Leary PJ, Bristow MR. Reply: Is Histamine H2 Receptor a Real?Promising Target for Prevention or?Treatment?of Heart Failure? J Am Coll Cardiol. 2016 11 01; 68(18):2029-2030.
Score: 0.527
-
Leary PJ, Tedford RJ, Bluemke DA, Bristow MR, Heckbert SR, Kawut SM, Krieger EV, Lima JA, Masri CS, Ralph DD, Shea S, Weiss NS, Kronmal RA. Histamine H2 Receptor Antagonists, Left?Ventricular Morphology, and Heart?Failure?Risk: The MESA Study. J Am Coll Cardiol. 2016 Apr 05; 67(13):1544-1552.
Score: 0.127
-
Leary PJ, Barr RG, Bluemke DA, Bristow MR, Kronmal RA, Lima JA, Ralph DD, Ventetuolo CE, Kawut SM. H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study. Ann Am Thorac Soc. 2014 Nov; 11(9):1379-86.
Score: 0.115
-
Bristow MR, Cubicciotti R, Ginsburg R, Stinson EB, Johnson C. Histamine-mediated adenylate cyclase stimulation in human myocardium. Mol Pharmacol. 1982 May; 21(3):671-9.
Score: 0.012
-
Ginsburg R, Bristow MR, Stinson EB, Harrison DC. Histamine receptors in the human heart. Life Sci. 1980 Jun 30; 26(26):2245-9.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|